Trending NewsTrending NewsNYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $73.34 +1.39 (+1.93%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$73.37 +0.03 (+0.04%) As of 08/8/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Solventum alerts:Sign Up Key Stats Today's Range$72.88▼$74.9850-Day Range$71.35▼$78.2152-Week Range$56.69▼$85.92Volume1.76 million shsAverage Volume629,965 shsMarket Capitalization$12.69 billionP/E Ratio33.95Dividend YieldN/APrice Target$85.75Consensus RatingHold Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 44% of companies evaluated by MarketBeat, and ranked 623rd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-16.57% Earnings GrowthEarnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 33.95, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 33.95, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.06.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.88. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 4.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.78% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Solventum has recently decreased by 12.50%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.78% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Solventum has recently decreased by 12.50%, indicating that investor sentiment is improving significantly. News and Social Media3.8 / 5News Sentiment0.90 News SentimentSolventum has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 26 news articles for Solventum this week, compared to 12 articles on an average week.Search Interest9 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.MarketBeat Follows7 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.05% of the stock of Solventum is held by insiders.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address SOLV Stock News HeadlinesSolventum ups financial guidance as tariff risks fadeAugust 8 at 2:34 PM | msn.comSolventum (SOLV) Fiscal Q2 EPS Jumps 8%August 8 at 9:32 AM | theglobeandmail.comAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.August 10 at 2:00 AM | Brownstone Research (Ad)Solventum shares surge as raised guidance tops expectationsAugust 8 at 9:32 AM | in.investing.comForecasting The Future: 3 Analyst Projections For SolventumAugust 8 at 9:32 AM | benzinga.comSolventum’s (NYSE:SOLV) Q2: Beats On RevenueAugust 8 at 9:32 AM | msn.comSolventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentumAugust 8 at 9:32 AM | msn.comSolventum Corporation (SOLV) Q2 2025 Earnings Call TranscriptAugust 8 at 7:08 AM | seekingalpha.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.06 at the beginning of 2025. Since then, SOLV shares have increased by 11.0% and is now trading at $73.34. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) posted its earnings results on Thursday, August, 7th. The company reported $1.69 EPS for the quarter, topping the consensus estimate of $1.45 by $0.24. Solventum's quarterly revenue was up 3.8% on a year-over-year basis. Read the conference call transcript. Who are Solventum's major shareholders? Top institutional shareholders of Solventum include Davis Selected Advisers (3.17%), Boston Partners (2.12%), Geode Capital Management LLC (2.06%) and Nuance Investments LLC (0.51%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AU Optronics (AUOTY). Company Calendar Last Earnings8/07/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Price Target for Solventum$85.75 High Price Target$103.00 Low Price Target$71.00 Potential Upside/Downside+16.9%Consensus RatingHold Rating Score (0-4)2.27 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$2.16 Trailing P/E Ratio33.95 Forward P/E Ratio11.15 P/E Growth1.88Net Income$478 million Net Margins4.52% Pretax Margin3.78% Return on Equity31.14% Return on Assets6.70% Debt Debt-to-Equity Ratio2.40 Current Ratio1.19 Quick Ratio0.85 Sales & Book Value Annual Sales$8.25 billion Price / Sales1.54 Cash Flow$9.94 per share Price / Cash Flow7.38 Book Value$17.13 per share Price / Book4.28Miscellaneous Outstanding Shares173,010,000Free Float172,926,000Market Cap$12.69 billion OptionableOptionable Beta0.52 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NYSE:SOLV) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.